TrialIntensive care medicine2021

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.

Yaseen M Arabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.